NCT00244816 2025-10-23
Taxoprexin® Treatment for Advanced Eye Melanoma
American Regent, Inc.
Phase 2 Completed
Clinical Trials
4 trialsNCT00249262 2025-09-26
Taxoprexin Treatment for Advanced Skin Melanoma
American Regent, Inc.
Phase 2 Completed
NCT00243867 2025-08-01
Taxoprexin Plus Carboplatin Treatment for Advanced Lung Cancer
American Regent, Inc.
Phase 3 Completed
NCT00146211 2007-12-27
TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease
Amarin Neuroscience Ltd
Phase 3 Completed